Healthcare provider profile · identity verified

Stephen H Pollom, M.D.

Internal Medicine · AVON, IN · NPI 1124062690

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	694	197
Amlodipine Besylate	Amlodipine Besylate	555	158
Levothyroxine Sodium	Levothyroxine Sodium	407	101
Tramadol Hcl	Tramadol Hcl	296	39
Gabapentin	Gabapentin	245	62
Omeprazole	Omeprazole	238	66
Irbesartan	Irbesartan	230	61
Lisinopril	Lisinopril	210	63
Losartan Potassium	Losartan Potassium	207	64
Eliquis	Apixaban	203	44
Pantoprazole Sodium	Pantoprazole Sodium	186	52
Metoprolol Succinate	Metoprolol Succinate	184	56
Metformin Hcl Er	Metformin Hcl	173	50
Metformin Hcl	Metformin Hcl	165	43
Tamsulosin Hcl	Tamsulosin Hcl	160	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	159	26
Rosuvastatin Calcium	Rosuvastatin Calcium	150	49
Allopurinol	Allopurinol	147	41
Pravastatin Sodium	Pravastatin Sodium	144	43
Simvastatin	Simvastatin	123	32
Metoprolol Tartrate	Metoprolol Tartrate	118	36
Valsartan	Valsartan	115	33
Hydrochlorothiazide	Hydrochlorothiazide	112	35
Carvedilol	Carvedilol	105	35
Escitalopram Oxalate	Escitalopram Oxalate	98	29
Trazodone Hcl	Trazodone Hcl	98	29
Potassium Chloride	Potassium Chloride	94	31
Mounjaro	Tirzepatide	93	15
Zolpidem Tartrate	Zolpidem Tartrate	92	12
Spironolactone	Spironolactone	88	28
Alendronate Sodium	Alendronate Sodium	80	21
Albuterol Sulfate Hfa	Albuterol Sulfate	72	29
Fluoxetine Hcl	Fluoxetine Hcl	72	17
Fluticasone Propionate	Fluticasone Propionate	72	29
Ozempic	Semaglutide	68	15
Duloxetine Hcl	Duloxetine Hcl	66	16
Meloxicam	Meloxicam	64	24
Lorazepam	Lorazepam	63	11
Alprazolam	Alprazolam	60	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Furosemide	Furosemide	56	19
Sertraline Hcl	Sertraline Hcl	56	14
Synthroid	Levothyroxine Sodium	55	13
Clonazepam	Clonazepam	51	suppressed
Benazepril Hcl	Benazepril Hcl	48	15
Jardiance	Empagliflozin	48	16
Clopidogrel	Clopidogrel Bisulfate	47	17
Citalopram Hbr	Citalopram Hydrobromide	46	13
Ezetimibe	Ezetimibe	46	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	20
Montelukast Sodium	Montelukast Sodium	45	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	45	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	12
Famotidine	Famotidine	39	11
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	39	13
Atenolol	Atenolol	38	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Warfarin Sodium	Warfarin Sodium	35	11
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Finasteride	Finasteride	31	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Methylprednisolone	Methylprednisolone	28	25
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	12
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Linzess	Linaclotide	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Jantoven	Warfarin Sodium	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Novolin N	Insulin Nph Human Isophane	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Torsemide	Torsemide	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Digoxin	Digoxin	17	suppressed
Novolin R	Insulin Regular, Human	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Fenofibrate	Fenofibrate	16	suppressed
Glipizide	Glipizide	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ramipril	Ramipril	16	suppressed
Topiramate	Topiramate	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Testosterone	Testosterone	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Baclofen	Baclofen	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Ibu	Ibuprofen	11	suppressed
Methimazole	Methimazole	11	suppressed
Prednisone	Prednisone	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error